DexCom showed strong growth, margin expansion, and Stelo's OTC launch unlocked new markets despite competitive and regulatory ...

Detailed price information for Integer Holdings Corp (ITGR-N) from The Globe and Mail including charting and trades.

Investing.com - UBS maintained its Buy rating and $106.00 price target on DexCom (NASDAQ:DXCM) following a Friday sell-off triggered by concerns about the company’s G7 continuous glucose monitoring ...

DexCom, Inc. (NASDAQ:DXCM) is one of the best growth stocks to buy and hold forever. On September 22, UBS reiterated a ‘Buy’ rating on the stock and a $106 price target. The research firm reiterated ...

Investing in bespoke processes can sidestep the inefficiencies of ‘lazy artificial intelligence (AI)’ in medical device ...

Rising Diabetes, Tech Innovations, and Home Care Models Drive CGM Adoption. Saudi Arabian Self-monitoring Blood Glucose ...

Abbott eyes 10% EPS growth in 2026 with CGM momentum, new nutrition contracts, and medical device launches driving global ...

Saudi Arabia CGM Market Surges with Sensor Innovation, Home Care Trends, and Strategic Collaborations Driving Growth Amid Rising Diabetes PrevalenceDublin, Oct. 14, 2025 (GLOBE NEWSWIRE) -- The "Saudi ...

Experts weigh in on the most promising AI applications, from diabetic retinopathy screening to smarter insulin delivery, and the barriers that remain to widespread adoption and access.

As diabetes continues to impact millions worldwide, the global non-invasive blood glucose monitoring devices market is poised ...